According to the Legislative Budget Board (LBB), SB 456 is not expected to have a significant fiscal impact on the State of Texas. The bill increases the criminal penalty for the unlawful purchase or sale of human organs from a Class A misdemeanor to a state jail felony and mandates the revocation of a physician's license if they knowingly use such an organ. While this change may slightly affect criminal justice operations and medical licensing enforcement, these impacts are anticipated to be minimal and absorbable within existing agency resources.

From a correctional perspective, the reclassification to a state jail felony could modestly increase the number of individuals incarcerated in state facilities. However, due to the rarity of such offenses, the fiscal note assumes that the overall effect on state correctional populations and the associated demand for correctional resources would not be significant.

Similarly, for local governments, the bill is not expected to impose major financial burdens related to enforcement, prosecution, or incarceration. Any additional workload or costs incurred by local law enforcement, judicial systems, or county jails are projected to be manageable within their current operational capacities.

Overall, SB 456 reflects a policy-focused enhancement of legal and professional accountability without imposing substantial new costs on state or local governments.

SB 456 strengthens Texas’s legal framework against the trafficking of human organs by upgrading the penalty for such offenses from a Class A misdemeanor to a state jail felony and mandating the revocation of a physician’s license if they knowingly use an illegally obtained organ. These changes reflect the serious ethical and human rights concerns associated with the global black market in organs, a multibillion-dollar industry that thrives on coercion and exploitation.

The bill promotes accountability and deters abuse without expanding the size or scope of government in a meaningful way. It does not create new agencies, grant rulemaking authority, or establish any permanent programs. Instead, it operates entirely within the bounds of the existing criminal justice and professional licensing infrastructure. The Texas Medical Board is already empowered to discipline physicians, and the criminal justice system already prosecutes related offenses—this bill simply adjusts the severity of the consequences in cases of willful misconduct.

Importantly, the Legislative Budget Board has determined that SB 456 will not impose a significant fiscal burden on state or local governments. The change in offense classification is not expected to appreciably increase prison populations or enforcement costs. Therefore, it does not create a new taxpayer burden.

Additionally, the legislation imposes no new regulatory burdens on the general public or the broader medical community. The license revocation provision only applies when a physician knowingly uses an organ acquired illegally. Legal organ donation, transplant systems, and ethical medical practice remain untouched and unaffected by this law.

In sum, SB 456 upholds ethical standards, protects individual liberty and public safety, and enforces professional accountability, without growing government, burdening taxpayers, or overregulating lawful actors. As such, Texas Policy Research recommends that lawmakers vote YES on SB 456.'

• Individual Liberty: The bill protects the bodily autonomy and human dignity of vulnerable individuals by criminalizing the coercive and exploitative practice of illegal organ sales. By deterring organ trafficking, SB 456 upholds the right of individuals to be free from bodily harm or coercion, especially those who might be pressured into selling organs under false pretenses or economic duress.
• Personal Responsibility: The bill reinforces the principle that individuals, particularly medical professionals, must be accountable for their actions. Physicians who knowingly participate in unethical or illegal procedures face license revocation, a strong but narrowly tailored consequence that encourages responsible conduct within the medical profession.
• Free Enterprise: The bill does not restrict legal commerce or interfere with lawful medical or organ donation systems. It targets only black-market transactions and unethical medical practices. While it introduces a penalty for a specific illegal transaction, it does not expand regulatory burdens on law-abiding businesses or medical institutions.
• Private Property Rights: Although the bill deals with human organs—a domain often debated in the context of bodily property—it does not introduce any new restrictions or redefine ownership rights. Instead, it reinforces longstanding ethical and legal boundaries regarding the non-commercialization of human body parts.
• Limited Government: The bill is tightly scoped and relies on existing institutions (criminal justice system and medical licensing boards) for enforcement. It does not create new agencies or regulatory regimes. The revocation of medical licenses is conditioned on “knowing” violations, protecting against arbitrary or excessive government intrusion.